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Breast Cancer among Women Living in Poverty:
Better Care in Canada than in the United States
Kevin M. Gorey, Nancy L. Richter, Isaac N. Luginaah, Caroline Hamm, Eric J. Holowaty,
Guangyong Zou, and Madham K. Balagurusamy
This historical study estimated the protective effects of a universally accessible, single-payer
health care system versus a multipayer system that leaves many uninsured or underinsured by
comparing breast cancer care of women living in high-poverty neighborhoods in Ontario
and California between 1996 and 2011. Women in Canada experienced better care, particularly as compared with women who were inadequately insured in the United States.
Women in Canada were diagnosed earlier (rate ratio [RR] = 1.12) and enjoyed better access
to breast conserving surgery (RR = 1.48), radiation (RR = 1.60), and hormone therapies
(RR = 1.78). Women living in high-poverty Canadian neighborhoods even experienced
shorter waits for surgery (RR = 0.58) and radiation therapy (RR = 0.44) than did such
women in the United States. Consequently, women in Canada were much more likely to
survive longer. Regression analyses indicated that health insurance could explain most of the
better care and better outcomes in Canada. Over this study’s 15-year time frame 31,500 late
diagnoses, 94,500 suboptimum treatment plans, and 103,500 early deaths were estimated in
high-poverty U.S. neighborhoods due to relatively inadequate health insurance coverage.
Implications for social work practice, including advocacy for future reforms of U.S. health
care, are discussed.
KEY WORDS:

breast cancer; health care reform; health insurance; Patient Protection and
Affordable Care Act; poverty; single-payer system

T

he population of people who live in poverty
in the United States rose markedly from 37.5
to 46.2 million between 2007 and 2011.
During this period, which has come to be known as
the Great Recession, the population of people in the
United States who were uninsured also increased significantly, to more than 50 million (DeNavas-Walt,
Proctor, & Smith, 2012). Including people who were
underinsured, those with health insurance but without the financial means of absorbing typically uncovered costs of care, doubled the estimated inadequately
insured population to 100 million (Kaiser Family
Foundation, 2012; Schapmire, Head, & Faul, 2012).
Along with presidential advocacy, this group probably
represented a social force that could no longer be
ignored and long-awaited reform of U.S. health care,
the Patient Protection and Affordable Care Act (ACA)
became law in 2010. Commonly called Obamacare,
it is bound to make health care accessible for tens of
millions more Americans (Congressional Budget Office [CBO], 2012). However, the same report estimated
that it could leave as many as 25 million people uninsured or underinsured.
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Canada is of particular comparative social policy
interest. Its poverty prevalence of approximately
10% did not increase significantly during the Great
Recession (Murphy, Zhang, & Dionne, 2012), and
its entire population is insured for medically necessary care by a single, public payer. Universal health
care is a strong element of Canada’s social safety net
that, relative to the United States’, seems to have
provided better protection during a time of economic decline. The National Association of Social Workers (2009) and regional social work
associations in coalition with others (for example,
Healthcare-Now, 2014) have long advocated for
single-payer reform. Although most celebrated the
passage of the ACA, their advocacy on behalf of
uninsured and underinsured people continues. Advocates, adversaries, scholars, and policymakers wonder the following: How much of an improvement is
the ACA likely to make on key health care indicators? And how much more improvement might be
realized if single-payer reform were enacted in the
United States? Definitive answers will necessitate
prospective investigations. In the meantime historical
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investigations can advance useful knowledge. This
study aims to advance such knowledge by examining evidence on one sentinel indicator among key
informative populations during an instructive period: breast cancer care among women who lived
in high-poverty U.S. or Canadian neighborhoods
during the years immediately prior to ACA’s
passage.
LITERATURE REVIEW

High-Poverty Neighborhoods in the
United States and Canada

Four of every 100 U.S. residents live in high-poverty
neighborhoods. These places, where 30% to 40%
or more of the people have very low incomes, have
been described as places of prevalent demographic
vulnerability ( Jargowsky, 2005; Wilson, 2012). In
addition to people with inadequate incomes, such
neighborhoods have high concentrations of people
of color, people who are unemployed or who have
withdrawn from the labor market, part-time service
workers, recipients of social assistance, and people
who are homeless. Such places seem particularly
distressed for their lack of social and economic capital (Kawachi, 1999). Adequate health insurance,
itself a type of social and economic capital, has been
observed to be profoundly lacking among people
who live in high-poverty U.S. neighborhoods,
especially among those who may need it most,
such as people with illnesses that require costly care.
For example, people with cancer in high-poverty
California neighborhoods were recently observed to
be nearly two times as likely to be uninsured, up to
12 times as likely to be insured by Medicaid, but only
half as likely to have private health insurance as were
their counterparts in relatively low-poverty neighborhoods. Of most policy interest was the fact that
better treatment access and outcomes observed
among residents of more affluent neighborhoods
were largely explained by the intermediate effect of
their having adequate health insurance, that is, private or Medicare coverage (Gorey et al., 2012, 2013).
There seems to be less descriptive information
about high-poverty neighborhoods in Canada. This
is perhaps not surprising as such neighborhoods
are less prevalent in Canada (Broadway, 1989;
W. Chen, Myles, & Picot, 2012). Still, they do exist.
In fact, two of every 100 Ontarians live in such
high-poverty neighborhoods where 40% or more
of the people spend two-thirds or more of their
income on life’s necessities (Gorey, 1998; Statistics
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Canada, 2002). A seemingly small estimate—half
that of the United States’—it represents a very sizable population of more than half a million Canadians. Though the health risks, including cancer
risks that Canadians are exposed to, are quite similar
to those that their counterparts in the United States
experience (Gorey, Holowaty, Laukkanen, Fehringer,
& Richter, 1998; Krieger et al., 2002; Lemstra,
Neudorf, & Opondo, 2006; Mustard, Derksen,
Berthelot, & Wolfson, 1999), Canadians living in
high-poverty neighborhoods seem to have one distinct advantage. They enjoy access to Canada’s
single-payer health care system. Consequently, such
between-country comparisons on cancer care in
high-poverty neighborhoods are likely to reveal the
relative risks of being uninsured or underinsured in
the United States.
Breast Cancer Care in High-Poverty U.S.
and Canadian Neighborhoods

Breast cancer care seems a very useful sentinel indicator of health care performance. The most common
type of cancer among women in North America,
directly affecting one of every eight to nine such
women during their lives; its prognosis is typically
excellent with early diagnosis and timely access to
the best treatments (Coleman et al., 2008). Moreover, for a number of reasons it may be particularly
instructive for Canada–U.S. comparisons. First, income has been observed to be strongly associated
with breast cancer care and survival in the United
States, but not in Canada (Gillan et al., 2012; Gorey,
2009; McKenzie & Jeffreys, 2009). Second, in the
United States women with private health insurance
or Medicare coverage are more likely to receive better care than are women with arguably less adequate
coverage, such as that provided through the Medicaid programs of many states, or none (Coburn
et al., 2008; Gorey et al., 2013; Schueler, Chu, &
Smith-Bindman, 2008; Subramanian et al., 2011).
And third, studies of breast cancer survival in
Canada and the United States have consistently observed better survival in Canada among the poor,
but no systematic differences within middle or upper
socioeconomic strata (Gorey, 2009). In short, breast
cancer care seems quite sensitive to the sorts of social
and policy forces that probably determine much of
the observed income and health insurance inequities
in North America.
Because cancer registries in Canada and the
United States do not typically include income data,
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these studies were all ecological with respect to
income. They used census tracts to define low-
income neighborhoods that typically only ranged
from 10% to 20% poor. So they had limited power
to study breast cancer care among the “truly disadvantaged” (Wilson, 2012) people who live in America’s poorest neighborhoods. A preliminary study
that described the experiences of such women with
breast cancer in Canada and the United States between 1998 and 2006 found that the Canadian
women experienced significantly better treatment
access and outcomes. They were diagnosed earlier
and were more likely to receive breast conserving
surgery (BCS) as well as radiation and hormone
therapies. Contrary to much political rhetoric, the
Canadian women were less likely to experience
long waits for surgery or radiation therapy (Gorey,
Luginaah, Hamm, Fung, & Holowaty, 2010). More
inclusive health insurance coverage in Canada was
advanced as the most plausible explanation, but this
theory was not directly tested as health insurance
variables were not available. Moreover, this study only
observed the experiences of 100 women, living in
poor, but not extremely poor, neighborhoods. The
present study aims to put this health insurance hypothesis to a more recent, focused, and powerful test.
HYPOTHESES

We are unaware of any study that has compared
breast cancer care between adequate samples of
women living in extremely impoverished neighborhoods in Canada and the United States who were
also known to be adequately insured, inadequately
insured, or uninsured. This one does so between
1996 and 2011. We hypothesized the following: (a)
Overall, Canadian women with breast cancer who
live in such high-poverty neighborhoods will experience better cancer care and survival compared with
their counterparts in the United States, (b) Canadian
breast cancer care and survival will be better when
compared with the care received by inadequately
insured Americans (uninsured or Medicaid insured),
and (c) relative protective effects among the Canadian women will be explained by the intermediate
effect of their all having health insurance.
METHOD

Sampling the Historical Cohorts

We chose to study California and Ontario to maximize both internal and external validity. They are
the most populous state and province, respectively,

and their comprehensive cancer registries contribute
to their respective national cancer surveillance systems with demonstrated validity (Gorey, Luginaah,
Holowaty, Fung, & Hamm, 2009; Hall, Schulze,
Groome, Mackillop, & Holowaty, 2006; Wright,
1996). This study secondarily analyzed the highpoverty strata of a California–Ontario breast cancer
database that originally randomly selected women
from high-, middle-, and low-poverty neighborhoods. Women with malignant breast cancer were
randomly selected from three geographic strata in
Ontario and California between 1996 and 2000:
very large metropolitan areas (Toronto versus San
Diego, San Francisco, and Los Angeles), smaller
metropolitan areas (Windsor versus Salinas,
Modesto, Stockton, Bakersfield, and Fresno), and
rural places. They have been followed, thus far, until
January 1, 2011. We retrospectively collected data
on breast cancer stage at diagnosis and treatments
from health records across the province of Ontario
to augment the Ontario Cancer Registry (OCR).
Given the relatively high cost, we were able to sample 300 women from high-poverty neighborhoods
in Ontario. We oversampled 1,950 women from
high-poverty neighborhoods in California. Over
sampling costs were negligible as all of this study’s
variables were routinely coded by the California
Cancer Registry (CCR). Bolstering statistical power
to detect meaningful between-country differences,
California participants served as multiple “controls”
for the Ontario participant “cases” in a ratio of 6.5 to
1. This study was powered to detect rate differences
of 10%, with 80% power at a two-tailed significance
level of 5% (Fleiss, Levin, & Paik, 2003; Hennessy,
Bilker, Berlin, & Strom, 1999). Subsample analyses
that were necessarily less powerful could be deemed
exploratory. Any such finding that met the more
liberal significance criterion of 10% was reported as
approaching significance ( p < .10).
High-Poverty Cohort Definitions

Conceptually similar definitions of economic deprivation are used by Statistics Canada and the U.S.
Census Bureau. Both are based on annual income
adjusted for household size, but the Canadian lowincome cutoff is approximately 140% of the U.S.
poverty threshold (Osberg, 2000). Although not
identical, our previous experience suggested that
these two measures could be used to construct very
similar “high-poverty” cohorts in California and
Ontario. After first linking eligible women who
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were diagnosed with breast cancer in California to
the 2000 census by their residential census tract, we
randomly selected our sample from tracts where 30%
or more of the households met the federal poverty
criterion (range = 30% to 100%, median = 36.8%
poor; U.S. Census Bureau, 2002). We then similarly
selected from the poorest Ontario tracts (range = 15.0%
to 52.8%, median = 22.7% low-income; Statistics
Canada, 2002). The resultant median annual household incomes in U.S. dollars (Bank of Canada, 2014)
were quite similar in California ($23,325) and Ontario ($25,100). We used census tracts to represent
extremely poor neighborhoods for this study of
cancer care in Canada and the United States for the
following reasons. First, validating studies in the
United States found such tracts to be more predictive of diverse personal health problems and social
ills than either smaller, block group or larger, zip
code–based measures (Krieger, Chen, Waterman,
Rehkopf, & Subramanian, 2003; Krieger et al.,
2002). Second, such tracts typically have approximately 4,000 inhabitants who are similarly poor on
both sides of the Canadian–U.S. border (Gorey et al.,
2010, 2011). And third, such census tract–based
poverty measures have been found to similarly predict the incidence of common types of cancer, including breast cancer, in Canada and the United
States (Gorey et al., 1998).
Cancer Registry Variables

Variables coded by the CCR or by our research
team to augment the OCR were as follows: stage
of disease at diagnosis (node negative [NN], node
positive [NP], or distally metastasized); receipt of
initial surgery; type of surgery (BCS or mastectomy); receipt of radiation therapy (RT), chemotherapy (CT), or hormone therapy (HT); wait times
from diagnosis to treatment; and survival time from
diagnosis to death or follow-up at 10 years. NN
disease has not yet spread to any regional lymph
nodes and is the most treatable type of breast cancer,
whereas distally metastasized disease has spread beyond regional lymph nodes to other parts of the
body. Surgery is indicated in most instances. BCS
or lumpectomy is recommended for most NN breast
cancers. Adjuvant treatments like RT, CT, and HT
are typically received after surgery to further assist
in the elimination or reduction of cancer cells
(Brant, Ziegler, & Kairon, 2014; McCready et al.,
2005; Morrow et al., 2002). Various long-wait
criteria that may be associated with breast cancer
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recurrences, metastases, or shorter survival were explored (Bilimoria et al., 2011; Z. Chen, King, Pearcey,
Kerba, & Mackillop, 2008).
These variables had less than 3% missing data.
Agreements were very high among three health record abstractors who collected augmenting data for
the OCR. An interrater reliability assessment of 50
randomly sampled records found that kappa coefficients ranged from 0.88 to 0.96 across study variables. For the California cohort, health insurance
status, the primary source of payment to the hospital or primary payer, was determined from health
records during the initial course of cancer treatment.
It was categorized as follows: uninsured (11.6%),
Medicaid (15.0%), Medicare (32.1%), or privately
insured (41.3%). Given our oversampling of highpoverty neighborhoods, the relatively low representation of people who were uninsured may seem
surprising. Note, though, that most initial breast
cancer care took place in hospitals where social
workers worked to connect people who were uninsured and poor to additional resources, typically
Medicaid.
Statistical Analyses

In comparing survival, early diagnosis, or treatment
rates between the two study cohorts, we first directly
adjusted them for age and any other significant and
substantial covariates using this study’s sample as the
standard and reported as rates per 100 participants
or percentages. Then we used standardized rate ratios (RRs) for between-country comparisons with
pooled 95% confidence intervals (CIs) derived from
the chi-square test. Logistic regression models tested
hypotheses about mediating effects of health insurance on country–breast cancer survival relationships.
We estimated odds ratios (ORs) and 95% CIs from
logistic regressions and imputed missing data from
full models. Binary survival outcomes (survived or
not) that were best predicted by significant main
effects and interactions were analyzed and reported
(Agresti, 2002; Hosmer & Lemeshow, 2000). In
each instance, we ran logistic regression models that
included four predictors: (1) country alone; (2)
country and health insurance; (3) country, health
insurance, and stage of disease at diagnosis; and (4)
country, health insurance, stage, and treatments.
These, respectively, assessed the significance of Canadian protective effects, their mediation or explanation by health insurance, and the main and any
additional mediating effects of early diagnosis and
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timely surgical and adjuvant treatments. Other
methodological details have been reported (Gorey
et al., 2010, 2011, 2012, 2013).

However, the survival rate among the women in
Ontario (78.5%) seemed somewhat better than that
of women who were uninsured or publicly insured
in California (70.0%, RR = 1.12). Next, betweencountry differences were observed to be much
greater for NP breast cancer. Overall, five-year
survival rates were significantly greater in Ontario
(RR = 1.23) and, as hypothesized, this apparent
benefit was greater when compared with that for
women who were uninsured or Medicaid insured
in California (RR = 1.27). The Californian women
with NP disease who were uninsured seemed quite
disadvantaged, as only about half of them survived
for five years (54.7%), whereas three-quarters of the

RESULTS

Description of Canadian Breast Cancer
Care Protections

Survival Rates. Comparisons of survival rates between study cohorts of women in high-poverty
neighborhoods of California and Ontario are displayed at the top of Table 1. First, we compared
women with NN disease on eight-year survival.
Overall, these cohorts of women with the most treatable type of breast cancer did not differ significantly.

Table 1: Comparisons of the Residents in California and Ontario’s
Poorest Neighborhoods on Breast Cancer Care and Survival:
Adjusted Rates and Standardized Rate Ratios
California
Sample Definition
Care Characteristic

Ontario

Ontario/California

Sample

Rate

Sample

Rate

n

%

n

%

RR

(95% CI)

Survival

Node negative (NN) disease
Eight-year survivala
Private
Uninsured or public
Node positive (NP) disease
Five-year survival
Private or Medicare
Uninsured or Medicaid
Uninsured
Metastasized disease
Three-year survivalb
Private or Medicare
Uninsured or Medicaid

724
370
354

76.8
83.2
70.0

125

78.5

1.02
0.94
1.12*

(0.92, 1.13)
(0.85, 1.04)
(0.99, 1.26)

623
418
205
80

59.9
62.5
58.0
54.7

97

73.7

1.23
1.18
1.27
1.35

(1.05, 1.45)
(1.00, 1.39)
(1.06, 1.53)
(1.07, 1.70)

129
78
51

21.8
29.9
13.7

8

33.4

1.53
1.12
2.44*

(0.39, 6.02)
(0.12, 10.33)
(0.84, 7.05)

300

65.0

1.06
1.01
1.12

(0.96, 1.17)
(0.90, 1.13)
(1.01, 1.24)

94.3
95.0
93.2

300

96.6

1.02*
1.02
1.04

(0.99, 1.05)
(0.98, 1.06)
(1.00, 1.08)

49.6

190

73.5

1.48

(1.31, 1.68)

58.8

1.49
1.37
1.60

(1.32, 1.69)
(1.20, 1.56)
(1.40, 1.82)
(continued )

Early Diagnosis

Entire sample
NN disease
Private
Uninsured or public

1,950
805
1,145

61.5
64.5
57.9
Surgical Treatment

Entire sample
Had surgeryc
Private or Medicare
Uninsured or Medicaid
NN disease & had surgery
Had BCSd

1,947
1,429
518
1,073

Adjuvant Treatments

Entire sample
Received radiation therapyc
Private
Uninsured or public

1,950
805
1,145

39.5
42.8
36.6

300
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Table 1: Continued
Sample Definition
Care Characteristic
Primary insurers

NN disease & had BCS
Received radiation therapyd
Privatee
Uninsured or public
Hormone receptor positive tumorf
Received hormone therapy
Private
Uninsured or public

California

Ontario

Ontario/California

Sample

Rate

Sample

Rate

RR

n

%

n

%

(95% CI)

589
270
319

66.4
80.8
60.6

147

70.6

1.06
0.87
1.17

(0.98, 1.14)
(0.77, 0.98)
(1.01, 1.35)

993
408
585

41.2
45.7
38.3

216

68.2

1.65
1.49
1.78

(1.44, 1.89)
(1.29, 1.73)
(1.53, 2.07)

10.4
9.1
12.4

290

7.2

0.69*
0.79
0.58

(0.45, 1.06)
(0.50, 1.24)
(0.36, 0.93)

5.7
2.9
14.2

96

6.2

1.09
2.14
0.44*

(0.46, 2.58)
(0.80, 5.75)
(0.18, 1.10)

Wait Times

Had surgery
1,835
60+ days wait for surgeryc
Private or Medicare
1,358
Uninsured or Medicaid
477
Non-metastasized disease, no chemotherapy
367
180+ days wait for RTc
Private or Medicare
289
Uninsured or Medicaid
78

Optimum Care: BCS < Two Months Postdiagnosis and RT < Four Months Postsurgery

NN & low or intermediate grade
Optimum cared
Private
Uninsured or public
Uninsured

624
244
345
56

44.5
47.4
43.1
33.8

85

64.0

1.44
1.35*
1.48
1.89

(1.16, 1.79)
(0.98, 1.86)
(1.13, 1.94)
(1.31, 2.72)

Notes: RR = standardized rate ratio, CI = confidence interval, BCS = breast conserving surgery, RT = radiation therapy. Bolded rate ratios were statistically significant at p < .05. Unless
noted otherwise, all rates were age-adjusted across these categories: 25 to 44, 45 to 54, 55 to 64, 65 to 74, and 75 or older.
aSamples were restricted to those less than 70 years of age.
bRates were age-adjusted across these categories: 25 to 64 and 65 or older.
cRates were age- and stage–adjusted across these categories: 25 to 64 and 65 or older, and NN and NP breast cancer.
dRates were age and tumor size-adjusted across these categories: 25 to 64 and 65 or older, and less than 20 mm and 20 or more mm.
eOnly between-country comparisons indicative of an American advantage.
fEstrogen or progesterone receptor positive.
*p < .10.

women with similarly advanced disease in Ontario
survived (73.7%, RR = 1.35). We then explored
three-year survival of women whose disease had
metastasized, a trend indicative of better survival in
Ontario was observed (RR = 1.53), and the survival
rate in Ontario (33.4%) was much greater than that
of women who were uninsured or Medicaid insured
in California (13.7%, RR = 2.44).
Diagnosis and Treatments. Under the subheading
of early diagnosis in Table 1 it can be seen that overall the two cohorts did not differ significantly on
early diagnosis rates. Moreover, women who were
privately insured in California (64.5%) had an early
diagnosis rate essentially identical to that of all Ontarian women (65.0%, RR = 1.01). However, the
Ontario rate was significantly better than that of the
aggregate rate among women who were uninsured
and Medicaid or Medicare insured in California
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(57.9%, RR = 1.12). The Ontarian women were
12% more likely to be diagnosed early than were the
uninsured or publicly insured women in California.
The analyses also strongly suggested that Ontarian
women with breast cancer living in extreme poverty
have better access to more effective treatments,
whether directed toward cure or palliation, especially
as compared with their inadequately insured Californian counterparts. Overall between-country differences were minuscule on the receipt of surgery,
which was received in nearly all instances. However,
about 4% fewer of the uninsured or Medicaid insured received surgical treatment of their breast cancers (RR = 1.04). Of course there are legitimate
reasons for refusing surgery. It should be noted that
surgery refusal rates were nearly identical among the
women in California (10.7%) and Ontario (10.0%)
who did not have surgery. The between-country
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d ivide was much greater when a specific surgery was
considered. Only half of the Californian cohort
received BCS (49.6%) compared with three-quarters
of the Ontarian cohort (73.5%, RR = 1.48), a very
large, hypothetically consistent Canadian benefit.
Adjuvant treatments are displayed next in Table 1.
Overall, RT was received by many more in Ontario
than in California (58.8% versus 39.5%, RR = 1.49),
and the access gap was even greater among the uninsured or publicly insured (36.6%, RR = 1.60).
When RT was most indicated, that is, for women
with NN disease who received BCS, there was no
overall difference between the cohorts on RT receipt.
But the Ontario RT rate (70.6%) was significantly
better than the aggregate rate among those who
were uninsured or Medicaid or Medicare insured
in California (60.6%, RR = 1.17). Alternatively, the
Ontario RT rate was significantly worse than the
rate among those who were privately insured in
California (80.8%, RR = 0.87). The pattern of HT
findings was similar to that of RT. HT was received
by many more in Ontario than in California (68.2%
versus 41.2%, RR = 1.65), and the gap was even
greater among the uninsured or publicly insured
(38.3%, RR = 1.78). No significant between-country
differences were observed on CT.
Wait Times. Two exemplary wait criteria are displayed in Table 1. Overall, the women in Ontario
seemed less likely to have waited for two months or
more between their diagnosis and surgery (7.2%
versus 10.4%, RR = 0.69). As hypothesized, women
with adequate insurance in California did not differ
significantly from women in Ontario on such long
waits for surgery, but those with inadequate insurance in California were substantially more likely to
experience long waits (12.4%, RR = 0.58). Ontarian women with non-metastasized disease not
treated with CT were also much less likely to have
experienced long waits of six months or more for
RT than were women with inadequate insurance in
California (6.2% versus 14.2%, RR = 0.44).
Optimum Care. We developed a nominal measure of optimum treatment of one of the most common and treatable types of breast cancer—NN and
low to intermediate grade (localized and “welldifferentiated” tumors that tend to grow and spread
slowly)—from four study variables: received BCS
within two months of diagnosis and received adjuvant RT within four months of surgery. Admittedly,
it is probably only one of a number of “optimum”
care criterions with some measure of clinical valid-

ity. About two-thirds of the Ontario cohort received
such optimum care (64.0%), but less than half of the
California cohort did (44.5%, RR = 1.44). Hypothetically consistent, the between-country optimum
care differential was significantly less when Ontarian
women were compared with women with private
insurance in California (47.4%, RR = 1.35). The
differential was much larger when considering the
uninsured in California (33.8%). The women in
Ontario were nearly twice as likely to receive optimum care (RR = 1.89).
Canadian Advantages Explained by Health
Insurance

Three survival analyses are displayed in Table 2: (1)
long-term, eight-year survival among women less
than 70 years of age at diagnosis, the majority of
whom would be expected to survive throughout
follow-up given life expectancies in the United
States and Canada, (2) five-year survival among all
participants, and (3) short-term, three-year survival
among women with metastasized disease, the majority of whom were probably not treated with the
intention to cure, but to palliate. In each instance,
model 1 demonstrated practically significant Canadian survival advantages (respective odds ratios
[ORs] of 1.56, 1.50, and 2.10) that, as hypothesized,
were substantially to completely mediated by the
large and positive effects of having adequate health
insurance in model 2. Significant main and interacting effects of early diagnosis (model 3) and treatment
access (model 4) were entered into regression models in temporal order. Early diagnosis and receipt of
RT and HT strongly predicted eight-year survival,
whereas the odds of survival diminished substantially
for those who waited two months or more for surgery. These diagnostic and treatment effects seemed
to be the same in both countries, as there was no
stage or treatment by country interactions. A very
similar pattern was observed for the prediction of
five-year survival by early diagnostic, RT, and surgical wait effects, but in this instance there was also
one significant interaction effect: early diagnosis by
country. The advantaging effect of being diagnosed
with NN disease was significantly larger for the U.S.
cohort (OR = 4.06, 95% CI 3.26, 5.06) than for the
Canadian cohort (OR = 1.91, 95% CI 1.07, 3.42).
We explored possible reasons for this and found that
when diagnosed later the Canadian women (30.7%)
were three times as likely as women in the United
States (9.7%) to be treated very thoroughly with CT,
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Table 2: Associations of Country, Health Insurance, Diagnostic, and Treatment
Characteristics with Breast Cancer Survival: Logistic Regression Models
Model 1
Characteristic

OR

(95% CI)

Model 2
OR

(95% CI)

Model 3
(95% CI)

OR

Model 4
OR

(95% CI)

Eight-Year Survival among 1,500 Women < 70 Years of Age at Diagnosisa

Country (Canadian advantage)
Medicare or private insurance
NN disease at diagnosis
Waited > 60 days for surgery
Received radiation therapy
Received hormone therapy

1.56

(1.12, 2.17)

1.29
1.70

(0.91, 1.82)
(1.34, 2.15)

1.27
1.56
3.89

(0.89, 1.82)
(1.21, 2.00)
(3.09, 4.89)

1.09
1.48
3.98
0.55
1.34
1.35

(0.75, 1.57)
(1.15, 1.91)
(3.15, 5.01)
(0.38, 0.78)
(1.06, 1.70)
(1.04, 1.75)

1.10
1.37
2.90
0.47
1.44
0.49

(0.81, 1.50)
(1.07, 1.76)
(2.32, 3.62)
(0.35, 0.65)
(1.17, 1.78)
(0.27, 0.90)

Five-Year Survival among all 2,250 Women in the Sampleb

Country (Canadian advantage)
1.50
Medicare or private insurance
NN disease at diagnosis
Waited > 60 days for surgery
Received radiation therapy
NN disease at diagnosis by country

(1.12, 1.99)

1.31*
1.66

(0.98, 1.77)
(1.31, 2.10)

1.33*
1.55
3.65

(0.98, 1.81)
(1.21, 1.97)
(2.98, 4.48)

Three-Year Survival among 137 Women with Metastasized Disease at Diagnosisc

Country (Canadian advantage)
Medicare or private insurance
Received chemotherapy
Received hormone therapy

2.10

(0.47, 9.41)

1.32
3.13

(0.27, 6.38)
(1.11, 8.78)

Not applicable

1.00
1.68
5.08
5.84

(0.09, 11.39)
(0.41, 6.92)
(1.00, 26.67)
(1.54, 22.14)

Notes: OR = odds ratio, CI = confidence interval, NN = node negative. Bolded ORs were statistically significant at p < .05.
aAll effects were age-adjusted across these categories: 25 to 44, 45 to 54, 55 or older.
bAll effects were age-adjusted across these categories: 25 to 44, 45 to 54, 55 to 64, 65 to 74, 75 or older.
cAll effects were age- and grade-adjusted across these categories: 25 to 64, 65 or older, and low to intermediate or high grade.
*p < .10.

RT, and HT (RR = 3.16, 95% CI 2.19, 4.57). For
the three-year model, survival odds were five- to
sixfold greater among women with metastasized
disease who had received CT or HT in either country. No significant effects of country remained after
health insurance, disease stage, and treatments were
accounted for (respective ORs of 1.09, 1.10, and
1.00, all nonsignificant).
DISCUSSION

This study compared breast cancer care in highpoverty neighborhoods in Canada and the United
States. Using breast cancer as a health care policy
sentinel we found consistent support for the hypothesis that Canadian women experienced better care
and outcomes in the years prior to passage of the
ACA. Such Canadian women were more likely than
their counterparts in the United States to receive
BCS, RT, and HT, and those with NP or metastasized disease survived longer. Contrary to prevalent
rhetoric, Canadian women were less likely to experience long waits for care. We also found consistent
support for the hypothesis that Canadian protections
were even greater when compared with those of U.S.
women who were uninsured or Medicaid insured.
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Such women in the United States were at greater
risk of receiving substandard care. They were diagnosed later; waited longer for treatment; had much
less access to BCS, RT, and HT; and were less likely to
survive. We also observed suggestive Medicare inadequacies. Most telling, women in the United States
who were uninsured or publicly insured by Medicaid or Medicare were much less likely than Canadian
women to receive optimum, evidence-based care.
Finally, three mathematical models cross-validated
the hypothesis that health insurance mediated between-country differences. Better three-, five-, and
eight-year outcomes among Canadian women were
primarily explainable by the fact of their more adequate health insurance.
Compared with Canadian women, uninsured
women in the United States received the most consistently substandard care. Risks of care inadequacies
were also observed among those who were Medicaid insured, and notable detriments were even observed among women in the United States whose
care was primarily covered by Medicare or by a
private insurer. These findings seem consistent with
well-known inequities in U.S. health care. Such admitted inequities have even come to be reflected in
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the language of U.S. health insurance. For example,
it may go without saying that those covered by
Medicare need to purchase additional Medigap coverage. Private insurance plans are called “bronze,
silver, gold, or platinum,” implying that certain
people have better coverage than others. The probability of its providing health insurance to tens of
millions more Americans notwithstanding (CBO,
2012), the ACA may not be able to rectify such
structural inequities. In fact, it has been estimated
that the vast majority of private plans purchased
through the ACA’s health insurance exchanges will
be bronze or silver plans with very high deductibles
(Wharam, Ross-Degnan, & Rosenthal, 2013). Similar structural inequities, including compromised
coverage with greater out-of-pocket expenses, have
been predicted for Medicaid’s expansion across 50
states (Magge, Cabral, Kazis, & Sommers, 2013). It
seems possible that many previously uninsured people may become underinsured under the ACA, and
it is people who live in poverty who will be least able
to absorb the additional, often great, out-of-pocket
costs of cancer care, for example (Gorey et al., 2012,
2013, 2014). This study suggests that a single-payer
system of universal health care coverage with global
budgets and without competition to cover the most
desirable people for the most profit (or least public
spending) could avoid such inequities.
Country-level Effect: Universal Access
versus Inadequate Insurance-based
Access Gaps

This study’s key country effects, estimated with standardized RRs or adjusted ORs, ranged from 1.12
for early diagnosis to 1.50 for the receipt of optimum care and survival. Their direction indicated
consistent Canadian protective effects, but one
might wonder about their practical significance in
population health or policy terms. The attribution
of risk or protection at the population level is a
function of three factors of which the effect size
(RR or OR) is only one. It is also important to
consider the size of the population at risk and the
prevalence of exposure to the risk factors being studied. In this instance, the central exposure or risk
factor to be mediated is a social one, poverty. The
other social exposure of interest is the risk of being
inadequately insured. Nearly a quarter of a million
women in the United States are diagnosed with
breast cancer each year, one of every five of whom
lives in poverty (American Cancer Society, 2012;

Iceland, 2013). This study estimated that six of every
10 such women are inadequately insured. That represents an annual population of 30,000 women in
the United States at risk of receiving less effective
care than similarly impoverished, but single-payer
covered, women in Canada.
Extrapolating these statistics and parameters, we
estimated that 2,100 women living in poverty with
breast cancer are diagnosed later, 6,300 treated less
optimally, and 6,900 die earlier each year in the
United States than would have, had they all enjoyed
access to a single-payer health care system. That is
an estimated 31,500 late diagnoses, 94,500 suboptimum treatments, and 103,500 premature deaths in
the United States during this study’s 15-year time
span. These striking inequities are probably only the
tip of the population health detriment iceberg, as
breast cancer accounts for less than 2% of the burden
of disease in the United States (Michaud et al., 2006).
We deem such large population risks attributable to
inadequate health insurance as evidence not only of
extraordinary social inequities, but also of profound
social injustices. The ACA will most assuredly begin
to close such between-country gaps. However, given
that substantial populations will probably remain
uninsured or underinsured in the United States
(CBO, 2012), substantial care and survival gaps are
also very likely to remain. This study strongly suggests that single-payer reform of health care in the
United States would close such gaps even further.
Limitations and Implications

Our analyses demonstrated that poverty and health
insurance matter, but what of ethnicity? Although
this study was not able to directly account for this
factor because the OCR does not code ethnicity,
we were able to conservatively compare the subsample of non-Hispanic white women in California
with the entire ethnically diverse sample in Ontario.
For example, we secondarily analyzed the optimum
care of women with imminently treatable breast
cancer, excluding all members of any ethnic minority group in California. Evidence of significantly
better access in Canada remained. Furthermore, the
substantial rate of suboptimum care among women
of color who were inadequately insured in California did not differ significantly from that of their
non-Hispanic white counterparts. In short, the disadvantaging effects of being uninsured or underinsured seem quite similar for all women living in
poverty in the United States, whether majority white
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or minority women of color. However, we think that
ethnic background or racialized group membership
still very much matters. Women of color comprised
more than half of this study’s Californian sample. And
compared with non-Hispanic white women, such
women of color were 40% more likely to be uninsured or Medicaid insured and 20% less likely to have
private health insurance. So approximately six of
every 10 of the late diagnoses, suboptimum treatments, and premature deaths in high-poverty California
neighborhoods were experienced by women of color
(Galea, Tracy, Hoggatt, DiMaggio, & Karpati, 2011;
Steenland & Armstrong, 2006). Even though the risks
associated with being inadequately insured are similar
for all women living in poverty in the United States,
because women of color are more likely to live in
poverty and to be inadequately insured, they are more
likely than non-Hispanic white women to experience
the injustices of contemporary U.S. health care. Race
still matters (West, 1993). Other potential limitations
have been discussed in previous articles (Gorey et al.,
2010, 2011, 2012, 2013).
Social Work Implications

The risk of living in poverty remains much greater
among racially or ethnically diverse people in the
United States. Moreover, this study affirmed again
that such people experience much greater risks of
having serious and costly illnesses, of being inadequately insured, and so of receiving inadequate
health care and of dying prematurely. Effective
Medicaid expansion through the ACA would go a
long way toward eliminating such oppressive, structural inequalities in U.S. health care. The uptake of
ACA changes are likely to be very challenging,
especially for those who live in poverty or near the
poverty line, and for racial, ethnic, or cultural minority people of color (Gorin, Gehlert, & Washington,
2010; Kimbrough-Melton, 2013; Sommers et al.,
2012). Recent national and statewide surveys consistently found prevalent lack of knowledge about
ACA changes, especially among those who might
benefit the most from them (Barcellos et al., 2014;
Blewett, Lukanen, Call, & Dahlen, 2013; Sinaiko,
Ross-Degnan, Soumerai, Lieu, & Galbraith, 2013).
In aggregate it seems that the majority of those
living in poverty are presently unprepared to effectively navigate the post-Obamacare health care
system. Implications for social work practice are
clear. Culturally sensitive social workers, performing
a continuum of roles, will be needed to ensure that
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people who are presently uninsured gain the best
possible health insurance, and when needed, enjoy
the highest-quality health care: outreach, teaching,
referral, care advocacy, coordination, and follow-up.
Finally, at the time of this writing, only 28 states and
the District of Columbia had “opted” to expand
Medicaid. Surely such an absurd structural inequality that would disenfranchise millions of Americans
cannot stand. Social workers in coalition with allied
professionals and diverse communities ought to advocate for the full enactment of recent health care
reforms across all 50 states as we continue to advocate
for future, single-payer reform of U.S. health care.
CONCLUSION

Women living in poverty with breast cancer receive
better care and are more likely to survive in Canada
than in the United States. Prevalent health insurance
inadequacies in the United States versus universal,
single-payer coverage in Canada largely explain this
between-country divide. The ACA will substantially
reduce such inequities, but additional reforms, including the introduction of a single-payer system,
would further reduce if not completely eliminate
them. Social justice and policy implications are clear.
Even as elements of the ACA continue to unfold,
social workers and allied advocates ought to continually strive to ensure that all Americans have access to the highest-quality health care.
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